Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of beta(2)-microglobulin yields a more accurate GELTAMO-IPI

Montalban, C; Diaz-Lopez, A; Dlouhy, I; Rovira, J; Lopez-Guillmermo, A; Alonso, S; Martin, A; Sancho, JM; Garcia, O; Sanchez, JM; Rodriguez, M; Novelli, S; Salar, A; Gutierrez, A; Rodriguez-Salazar, MJ; Bastos, M; Dominguez, JF; Fernandez, R; de Vill

Montalban, C (reprint author), MD Anderson Canc Ctr, Dept Haematol, Madrid, Spain.

BRITISH JOURNAL OF HAEMATOLOGY, 2017; 176 (6): 918

Abstract

The study included 1848 diffuse large B-cell lymphoma (DLBCL) patients treated with chemotherapy/rituximab. The aims were to validate the National Com......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索